Deep Learning Model Improves Radiologists’ Performance in Detection and Classification of Breast Lesions

Autor: Lu-Wen Xing, Gui-Hua Yang, Bao-Qing Li, Wang Yichuan, Jie Liang, Yan-Jie Shi, Liwei Wang, Jing-Bo Du, Yu-Hong Qu, Hai-Jiao Li, Yan-Yu Yin, Yi Li, Lin Ye, Rong Long, Bing Xu, Dengbo Chen, Kexin Zhang, Sun Yingshi, Xiao-Ting Li, Min Cao, Rui-Jia Sun, Juan Zhu, Jie Zhang, Dong Wang, Ming-Bin Cheng
Rok vydání: 2021
Předmět:
DOI: 10.21203/rs.3.rs-746374/v1
Popis: Background: Computer-aided diagnosis using deep learning algorithms has been initially applied in the field of mammography, but there is no large-scale clinical application.Methods: This study proposed to develop and verify an artificial intelligence model based on mammography. Firstly, retrospectively collected mammograms from six centers were randomized to a training dataset and a validation dataset for establishing the model. Secondly, the model was tested by comparing 12 radiologists’ performance with and without it. Finally, prospectively multicenter mammograms were diagnosed by radiologists with the model. The detection and diagnostic capabilities were evaluated using the free-response receiver operating characteristic (FROC) curve and ROC curve.Results: The sensitivity of model for detecting lesion after matching was 0.908 for false positive rate of 0.25 in unilateral images. The area under ROC curve (AUC) to distinguish the benign from malignant lesions was 0.855 (95% CI: 0.830, 0.880). The performance of 12 radiologists with the model was higher than that of radiologists alone (AUC: 0.852 vs. 0.808, P = 0.005). The mean reading time of with the model was shorter than that of reading alone (80.18 s vs. 62.28 s, P = 0.03). In prospective application, the sensitivity of detection reached 0.887 at false positive rate of 0.25; the AUC of radiologists with the model was 0.983 (95% CI: 0.978, 0.988), with sensitivity, specificity, PPV, and NPV of 94.36%, 98.07%, 87.76%, and 99.09%, respectively.Conclusions: The artificial intelligence model exhibits high accuracy for detecting and diagnosing breast lesions, improves diagnostic accuracy and saves time.Trial registration: NCT, NCT03708978. Registered 17 April 2018, https://register.clinicaltrials.gov/prs/app/ NCT03708978
Databáze: OpenAIRE